Editas Medicine Inc. (EDIT)
NASDAQ: EDIT
· Real-Time Price · USD
1.45
0.06 (4.32%)
At close: May 09, 2025, 3:59 PM
1.45
0.35%
After-hours: May 09, 2025, 05:34 PM EDT
4.32% (1D)
| Bid | 1.45 |
| Market Cap | 120.96M |
| Revenue (ttm) | 32.31M |
| Net Income (ttm) | -237.09M |
| EPS (ttm) | -2.88 |
| PE Ratio (ttm) | -0.5 |
| Forward PE | -1.26 |
| Analyst | Hold |
| Ask | 1.53 |
| Volume | 1,506,233 |
| Avg. Volume (20D) | 3,732,204 |
| Open | 1.42 |
| Previous Close | 1.39 |
| Day's Range | 1.41 - 1.53 |
| 52-Week Range | 0.91 - 6.69 |
| Beta | 2.15 |
About EDIT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EDIT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EDIT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-23.81%
Editas Medicine shares are trading lower after Sti...
Unlock content with
Pro Subscription
4 months ago
-5.03%
Editas Medicine shares are trading higher after the company announced plans to transition to an in vivo focus and initiated a reduction in headcount, aiming to eliminate approximately 65% of its workforce over the next six months.
2 months ago · seekingalpha.com
Editas Medicine, Inc. (EDIT) TD Cowen 45th Annual Health Care Conference TranscriptEditas Medicine, Inc. (NASDAQ:EDIT ) TD Cowen 45th Annual Health Care Conference March 3, 2025 2:30 PM ET Company Participants Gilmore O'Neill - Chief Executive Officer Erick Lucera - Chief Financial ...